LINC01816

Across TCGA pan-cancer cohorts, LINC01816 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01816 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01816 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01816 expression acts as an unfavorable survival marker, although some lineages such as OV and UCS show a favorable association.

OV, UCEC, and UCS are the cancer types where LINC01816 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Quartile	IV	0.811	0.419	.002	32	view →
UCEC	DFS	Tertile	All	0.594	0.787	.011	24	view →
UCS	DFS	Tertile	II,III,IV	0.625	0.290	.015	22	view →
READ	DFS	Quartile	III,IV	1.000	0.504	.008	21	view →
LUAD	DFS	Tertile	All	0.745	0.872	.008	20	view →
KIRP	OS	Tertile	All	0.974	0.886	.007	20	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	18	view →
ACC	OS	Quartile	III,IV	1.000	0.424	.008	18	view →
MESO	OS	Quartile	All	0.459	0.234	.005	12	view →
KIRC	DFS	Quartile	All	0.711	0.527	.003	12	view →
COAD	DFS	Median	II,III,IV	0.418	0.655	.014	10	view →
PRAD	OS	Tertile	All	1.000	0.827	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01816–OV (OS)

Open the OV breakdown →